The Rocky Mountain Interventional Endoscopy 2020 Course offers the following programs for Gastroenterologists, Gastrointestinal Surgeons, and Gastrointestinal Nurses:
GI Nurse and Technicians Program – Thursday, February 6, 2020
Fellows Advanced Endoscopy Program – Thursday, February 6, 2020
Rocky Mountain Interventional Endoscopy Main Course – Friday - Saturday, February 7 - 8, 2020
The University of Colorado School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Colorado School of Medicine designates this live activity for a maximum of 15.5 AMA PRA Category 1 Credits.
Physicians should claim only the credit commensurate with the extent of their participation in this activity.
At the conclusion of this activity, the participants should be able to:
Improve the performance of ERCP and EUS by understanding established indications, contraindications, techniques to optimize success, and minimize adverse events. This includes advanced and alternative methods of bile duct access and to employ therapeutic options of benign and neoplastic lesions in the pancreas and bile duct.
Implement the best endoscopic identification and treatment strategies for patients with pancreatitis and inflammatory bowel disease and understand the importance of the role of new techniques and technologies to improve and expand treatment options and enhance patient education of alternatives to minimally invasive and open surgical options.
Integrate practice guidelines and expert opinion in the identification and treatment of complex colonic polyps and patients at risk for polyposis syndromes. Implement the best endoscopic techniques to remove pre-malignant colonic lesions and to determine when surgical resection may be necessary.
Identify pancreatic cysts and which characteristics may suggest pre-malignant disease and incorporate the most current guidelines for surveillance and when to consider surgical resection.
Incorporate the most current algorithms in the treatment of upper GI bleeding and benign esophageal disorders such as eosinophilic esophagitis and achalasia.